Leslie Tari - 13 Mar 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
13 Mar 2023
Net transactions value
-$11,570
Form type
4
Filing time
13 Mar 2023, 21:21:27 UTC
Previous filing
27 Jan 2023
Next filing
29 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Sale $11,570 -7,562 -3.8% $1.53 190,179 13 Mar 2023 Direct F1
holding CDTX Common Stock 1,484 13 Mar 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.